View on Pubmed.gov 21994855 | View on doi.org 10.4061/2011/41...
The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma.
- Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200438, China.
Abstract
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer worldwide; despite the curative treatment for HCC, the rate of tumor recurrence after hepatectomy remains high. Tumor recurrence can occur early (<2 years) or late (>2 years) as metastases or de novo tumors. Several tumor factors were associated with HCC recurrence; high hepatitis B virus (HBV) load is the major risk factor for late recurrence of HCC after resection. Preoperative antiviral therapy improves liver function, and postoperative reduce HCC recurrence. In this paper, we focus on antiviral treatment to improve the liver function, prevent recurrence, and lengthen the overall survival for HBV-related HCC.
References
N Engl J Med. 2005 Jun 30;352(26):2673-81
Liver Int. 2008 Mar;28(3):393-401
Ann Intern Med. 1993 Aug 15;119(4):312-23
Liver Int. 2004 Apr;24(2):149-60
Cited by 9 citations (total)
Journal Article Research Support, N.I.H., Extramural Review
Hepatocellular carcinoma: important biomarkers and their significance in molecular diagnostics and therapy.
Electronic publication date December 13, 2012
B Sengupta [...] S A Siddiqi et al.
The increasing incidence of hepatocellular carcinoma (HCC) is of great concern not only in the United States but throughout the...
Journal Article
Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy.
Electronic publication date February 23, 2021
Shousheng Liu [...] Ming Zhao et al.
BACKGROUND
This study aimed to investigate the influence of hepatic artery infusion chemotherapy (HAIC) on hepatitis B virus (HBV) reactivation in...
Conflict of interest statement
MeSH
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •